TRAF6 and breast carcinoma: In Rezaeian's study [21], the hypoxia-responsive TRAF6 overexpression promotes breast cancer progression and metastasis to lung and spinal bone, and targeting of TRAF6 reduces breast cancer metastasis, opening up opportunities for therapeutic intervention.